Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Oncogenomics
  • Published:

Groups of p53 target genes involved in specific p53 downstream effects cluster into different classes of DNA binding sites

Abstract

The tumor suppressor protein p53, once activated, can cause either cell cycle arrest or apoptosis through transactivation of target genes with p53 DNA binding sites (DBS). To investigate the role of p53 DBS in the regulation of this profound, yet poorly understood decision of life versus death, we systematically studied all known and potential p53 DBS. We analysed the DBS separated from surrounding promoter regions in yeast and mammalian assays with and without DNA damage. p53 efficiently utilized the DBS of MDM2 and of genes connected to cell cycle arrest, DNA repair and the death receptor pathway of apoptosis. However, p53 was unable to utilize two-thirds of the isolated DBS, a subset that included almost all DBS of apoptosis-related genes. Neither ASPP2, a p53-interacting protein reported to specifically stimulate p53 transcriptional activity on apoptosis-related promoters, nor DNA damage resulted in p53 utilization of isolated DBS of apoptosis-related genes. Thus, a major regulation of p53 activity occurs at the level of p53 DBS themselves by posing additional requirements for the successful utilization of apoptosis-related DBS.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 6
Figure 4
Figure 5

Similar content being viewed by others

References

  • Baker SJ, Markowitz S, Fearon ER, Willson JK, Vogelstein B . 1990 Science 249: 912–915

  • Bates S, Vousden KH . 1999 Cell. Mol. Life Sci. 55: 28–37

  • Brachmann RK, Vidal M, Boeke JD . 1996 Proc. Natl. Acad. Sci. U S A 93: 4091–4095

  • Brachmann RK, Yu K, Eby Y, Pavletich NP, Boeke JD . 1998 EMBO J. 17: 1847–1859

  • Campomenosi P, Monti P, Aprile A, Abbondandolo A, Frebourg T, Gold B, Crook T, Inga A, Resnick MA, Iggo R, Fronza G . 2001 Oncogene 20: 3573–3579

  • Contente A, Dittmer A, Koch MC, Roth J, Dobbelstein M . 2002 Nat. Genet. 30: 315–320

  • De Laurenzi V, Costanzo A, Barcaroli D, Terrinoni A, Falco M, Annicchiarico-Petruzzelli M, Levrero M, Melino G . 1998 J. Exp. Med. 188: 1763–1768

  • Di Como CJ, Prives C . 1998 Oncogene 16: 2527–2539

  • el-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW, Vogelstein B . 1992 Nat. Genet. 1: 45–49

  • el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B . 1993 Cell 75: 817–825

  • Elkeles A, Juven-Gershon T, Israeli D, Wilder S, Zalcenstein A, Oren M . 1999 Mol. Cell. Biol. 19: 2594–2600

  • Flores ER, Tsai KY, Crowley D, Sengupta S, Yang A, McKeon F, Jacks T . 2002 Nature 416: 560–564

  • Friedlander P, Legros Y, Soussi T, Prives C . 1996 J. Biol. Chem. 271: 25468–25478

  • Funk WD, Pak DT, Karas RH, Wright WE, Shay JW . 1992 Mol. Cell. Biol. 12: 2866–2871

  • Haupt Y, Maya R, Kazaz A, Oren M . 1997 Nature 387: 296–299

  • Hengartner MO . 2000 Nature 407: 770–776

  • Hupp TR, Meek DW, Midgley CA, Lane DP . 1992 Cell 71: 875–886

  • Ko LJ, Prives C . 1996 Genes Dev. 10: 1054–1072

  • Kubbutat MH, Jones SN, Vousden KH . 1997 Nature 387: 299–303

  • Lane D . 2001 Nature 414: 25–26

  • Levine AJ . 1997 Cell 88: 323–331

  • Ludes-Meyers JH, Subler MA, Shivakumar CV, Munoz RM, Jiang P, Bigger JE, Brown DR, Deb SP, Deb S . 1996 Mol. Cell. Biol. 16: 6009–6019

  • Miyashita T, Reed JC . 1995 Cell 80: 293–299

  • Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B . 1997 Nature 389: 300–305

  • Prives C . 1998 Cell 95: 5–8

  • Prives C, Hall PA . 1999 J. Pathol. 187: 112–126

  • Rich T, Allen RL, Wyllie AH . 2000 Nature 407: 777–783

  • Samuels-Lev Y, O'Connor DJ, Bergamaschi D, Trigiante G, Hsieh JK, Zhong S, Campargue I, Naumovski L, Crook T, Lu X . 2001 Mol. Cell. 8: 781–794

  • Seol DW, Chen Q, Smith ML, Zarnegar R . 1999 J. Biol. Chem. 274: 3565–3572

  • Shin TH, Paterson AJ, Kudlow JE . 1995 Mol. Cell. Biol. 15: 4694–4701

  • Sikorski RS, Hieter P . 1989 Genetics 122: 19–27

  • Sionov RV, Haupt Y . 1999 Oncogene 18: 6145–6157

  • Szak ST, Mays D, Pietenpol JA . 2001 Mol. Cell. Biol. 21: 3375–3386

  • Thornborrow EC, Manfredi JJ . 1999 J. Biol. Chem. 274: 33747–33756

  • Thornborrow EC, Manfredi JJ . 2001 J. Biol/ Chem. 276: 15598–15608

  • Tokino T, Thiagalingam S, el-Deiry WS, Waldman T, Kinzler KW, Vogelstein B . 1994 Hum. Mol. Genet. 3: 1537–1542

  • Urist M, Prives C . 2002 Cancer Cell 1: 311–313

  • Vidal M, Brachmann RK, Fattaey A, Harlow E, Boeke JD . 1996 Proc. Natl. Acad. Sci. USA 93: 10315–10320

  • Vogelstein B, Lane D, Levine AJ . 2000 Nature 408: 307–310

  • Vousden KH . 2000 Cell 103: 691–694

  • Wang T, Kobayashi T, Takimoto R, Denes AE, Snyder EL, el-Deiry WS, Brachmann RK . 2001 EMBO J. 20: 6404–6413

  • Yang A, Kaghad M, Caput D, McKeon F . 2002 Trends Genet. 18: 90–95

Download references

Acknowledgements

We thank WS El-Deiry, H McLeod, G Melino, M Oren and B Vogelstein for providing reagents and Nataya Boonmark for constructing the Cep4-ASPP2 plasmid. This work was supported in part by grants from the James S McDonnell Foundation and National Institutes of Health grants CA81511 (RK Brachmann) and CA76316 (L Naumouski).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rainer K Brachmann.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Qian, H., Wang, T., Naumovski, L. et al. Groups of p53 target genes involved in specific p53 downstream effects cluster into different classes of DNA binding sites. Oncogene 21, 7901–7911 (2002). https://doi.org/10.1038/sj.onc.1205974

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205974

Keywords

This article is cited by

Search

Quick links